跳转至内容
Merck
  • FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53.

FKBP25, a novel regulator of the p53 pathway, induces the degradation of MDM2 and activation of p53.

FEBS letters (2009-01-27)
Anna Maria Ochocka, Petros Kampanis, Samantha Nicol, Nerea Allende-Vega, Miranda Cox, Lynnette Marcar, Diane Milne, Frances Fuller-Pace, David Meek
摘要

The p53 tumour suppressor protein is tightly controlled by the E3 ubiquitin ligase, mouse double minute 2 (MDM2), but maintains MDM2 expression as part of a negative feedback loop. We have identified the immunophilin, 25kDa FK506-binding protein (FKBP25), previously shown to be regulated by p53-mediated repression, as an MDM2-interacting partner. We show that FKBP25 stimulates auto-ubiquitylation and proteasomal degradation of MDM2, leading to the induction of p53. Depletion of FKBP25 by siRNA leads to increased levels of MDM2 and a corresponding reduction in p53 and p21 levels. These data are consistent with the idea that FKBP25 contributes to regulation of the p53-MDM2 negative feedback loop.

材料
货号
品牌
产品描述

Sigma-Aldrich
抗肌动蛋白(20-33) 兔抗, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
抗Myc标签抗体,克隆9E10, clone 9E10, Upstate®, from mouse